Taken together, our results indicate that Trib1 regulates the function of mitochondria and brown adipocytes in mice, suggesting its potential as a new target for the treatment of metabolic diseases such as hyperlipidaemia, fatty liver, and obesity. This evidence concerns the gene TRIB1 and metabolic disease.